Martha Shadan, President and CEO of Miach Orthopaedics, Inc., joins us for this episode. She has more than three decades of experience in the life science industry as a business leader in a variety of both large and start-up organizations.

We hear about her industry experience as a leader. During 2018, Shadan served as global vice president of marketing at Smith & Nephew, a role she assumed after the company acquired Rotation Medical, where she was president and CEO. Shadan led Rotation Medical through FDA approval and commercialization of the Rotation Medical Bioinductive Implant for rotator cuff tears (now known as REGENETEN™), as well as the company’s acquisition by Smith & Nephew in December 2017. Prior to joining Rotation Medical, she was the president of the Trauma Division at Zimmer where she managed the P&L for the global business. Shadan served at Covidien as vice president/general manager of Vascular Therapies and vice president/general manager of BioSurgery and Sports Surgery.

Topics include:

-Miach Orthopaedics' proprietary, bio-engineered Bridge-Enhanced® ACL Restoration (BEAR®) Implant. They recently received FDA clearance and are moving towards commercialization in select areas shortly. It is a proprietary bio-engineered implant used to facilitate healing of the torn ACL. Unlike reconstruction, which is the current standard of care, the BEAR Implant does not require a second surgical wound site to remove a healthy tendon from another part of the leg or using a deceased donor’s tendon. The BEAR Implant acts as a bridge between the two ends of the torn ACL.

-We also discuss important advice for medical device listeners in their careers.

Find out more about Martha Shadan here and find out more about Miach Orthopaedics, Inc. here.

For MD’s, click on the EARN CME link below to capture quick reflections on each learning & how it applies to your day-to-day to unlock a total of 1 AMA PRA Category 1 CMEs.